Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Intelligent Bio Solutions Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 8 | 9 | +1 |
| Shares | 76.8K | 877.2K | +800.3K (+1,041.8%) |
| Value | $107.5K | $1.26M | +$1.16M (+1,074.4%) |
New holders (4)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 613,892 | $884.0K | 0.00% |
| Altium Capital Management LP | 149,252 | $214.9K | 0.62% |
| Susquehanna International Group, LLP | 35,487 | $51.1K | 0.00% |
| Goldman Sachs Group Inc | 12,817 | $18.5K | 0.00% |
Sold out (3)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 15,397 | $21.6K |
| Ground Swell Capital, LLC | 10,402 | $14.6K |
| Tower Research Capital LLC (TRC) | 5,798 | $8.12K |